KDR and neoplasm: Importantly, galectin-1 co-localized with VEGFR2 in the new vessels (Fig. 4G–I), suggesting the VEGFR2-mediated pathogenic role of galection-1 in PDR as well as in tumor angiogenesis18, 21.